ADMA Biologics Inc (ADMA)
6.81
+0.07
(+1.04%)
USD |
NASDAQ |
May 03, 16:00
6.80
-0.01
(-0.15%)
After-Hours: 20:00
ADMA Biologics Gross Profit (Quarterly): 31.09M for Dec. 31, 2023
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 31.09M |
September 30, 2023 | 24.65M |
June 30, 2023 | 16.69M |
March 31, 2023 | 16.51M |
December 31, 2022 | 14.18M |
September 30, 2022 | 9.657M |
June 30, 2022 | 7.769M |
March 31, 2022 | 3.662M |
December 31, 2021 | 3.511M |
September 30, 2021 | 0.3853M |
June 30, 2021 | -1.002M |
March 31, 2021 | -1.722M |
December 31, 2020 | -5.155M |
September 30, 2020 | -1.579M |
June 30, 2020 | -5.708M |
March 31, 2020 | -6.630M |
December 31, 2019 | 0.3454M |
September 30, 2019 | -0.6937M |
June 30, 2019 | -3.930M |
March 31, 2019 | -5.877M |
December 31, 2018 | -7.086M |
September 30, 2018 | -4.934M |
June 30, 2018 | -4.989M |
March 31, 2018 | -8.201M |
December 31, 2017 | 0.08M |
Date | Value |
---|---|
September 30, 2017 | -6.562M |
June 30, 2017 | -0.9346M |
March 31, 2017 | 1.013M |
December 31, 2016 | 1.313M |
September 30, 2016 | 1.202M |
June 30, 2016 | 0.9275M |
March 31, 2016 | 0.8575M |
December 31, 2015 | 1.009M |
September 30, 2015 | 0.7396M |
June 30, 2015 | 0.5236M |
March 31, 2015 | 0.5935M |
December 31, 2014 | 0.5319M |
September 30, 2014 | 0.4982M |
June 30, 2014 | 0.5595M |
March 31, 2014 | 0.5835M |
December 31, 2013 | 0.1416M |
September 30, 2013 | 0.3811M |
June 30, 2013 | 0.2575M |
March 31, 2013 | 0.2639M |
December 31, 2012 | 0.143M |
September 30, 2012 | 0.2156M |
June 30, 2012 | 0.0882M |
March 31, 2012 | 0.0044M |
December 31, 2011 | 0.00 |
September 30, 2011 | 0.00 |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
-6.630M
Minimum
Mar 2020
31.09M
Maximum
Dec 2023
5.37M
Average
0.3853M
Median
Sep 2021
Gross Profit (Quarterly) Benchmarks
Vanda Pharmaceuticals Inc | 41.81M |
ANI Pharmaceuticals Inc | 78.23M |
Ligand Pharmaceuticals Inc | 26.46M |
Johnson & Johnson | 14.87B |
Puma Biotechnology Inc | 47.86M |